Polymorphisms and colorectal tumor risk

Gastroenterology

Volumn 121, Issue 2, 2001, Pages 282-301

  Houlston, Richard S ^a   Tomlinson, Ian P M ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; ARYLAMINE ACETYLTRANSFERASE; GENE PRODUCT; GLUTATHIONE TRANSFERASE MU; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE THETA; N ACETYLTRANSFERASE 1; UNCLASSIFIED DRUG;

ADENOMATOSIS; ALLELE; ARTICLE; CANCER INCIDENCE; CANCER RISK; COLON POLYPOSIS; COLORECTAL CANCER; COLORECTAL TUMOR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; PENETRANCE; PRIORITY JOURNAL;

EID: 0034909923     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.26265     Document Type: Article

References (109)

1. Colorectal carcinoma
2. Risk and surveillance of individuals with heritable factors for colorectal cancer
3. Epidemiology of familial adenomatous polyposis in Finland: Impact of family screening on the colorectal cancer rate and survival
4. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome)
5. Genetics of common cancers
6. The future of genetic studies of complex human disease
7. A genetic model for colorectal tumori-genesis
8. Genetic pathways in colorectal cancer
9. Metabolic polymorphisms and cancer susceptibility
10. CYPIA1
11. Polymorphic NATs and cancer predisposition
12. Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2′-dimethyl-4-aminobiphenyl
13. The glutathione S-transferases: Influence of polymorphism on cancer susceptibility
14. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: Relevance to xenobiotic metabolism and toxicity
15. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer
16. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis
17. CpG island methylator phenotype in colorectal cancer
18. Exon-specific DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine. Modulation by dietary folate
19. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
20. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
21. Mom1 leads the pack
22. Absence of secretory phospholipase A2 gene alterations in human colorectal cancer
23. Metabolic epidemiology of colon cancer. Faecal bile acids and neutral sterols in colon cancer patients and patients with adenomaous polyps
24. Apolipoprotein E polymorphism and atherosclerosis
25. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus
26. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
27. The Li-Fraumeni syndrome: An inherited susceptibility to cancer
28. Production of tumour necrosis factor/cachectin by human T cell lines and peripheral blood lymphocytes stimulated by phorbol myristrate acetate and anti-CD3 antibody
29. The study of tumour necrosis factor beta polymorphism in lung cancer patients
30. 10.5kb homozygote of tumour necrosis factor-beta gene is associated with a better prognosis in gastric cancer patients
31. Meta-analysis in clinical trials
32. Bias in meta-analysis detected by a simple graphical test
33. A simple approximation for calculating sample sizes for comparing independent proportions
34. Role of aromatic amine acetyltransferase in human colorectal cancer
35. Acetylation phenotype in colorectal carcinoma
36. Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma
37. Ha-ras restriction fragment length polymorphisms in colorectal cancer
38. Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn’s disease
39. Acetylator polymorphism in human colorectal carcinoma
40. The human glutathione S-transferases: A case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma
41. Human acetylator genotype: Relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol
42. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer
43. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer
44. CYP1A1 genetic polymorphisms and in situ colorectal cancer
45. Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer
46. Relation between the occurrence of K-ras gene point mutations and genotypes of polymorphic N-acetyltransferase in human colorectal carcinomas
47. Intron splice acceptor site sequence variation in the hereditary non-polyposis colorectal cancer gene hMSH2
48. P53 germ line haplotypes associated with increased risk for colorectal cancer
49. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer
50. Glutathione S-transferase M1 and T1 polymorphisms: Susceptibility to colon cancer and age of onset
51. Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas
52. Acetylation polymorphism and prevalence of colorectal adenomas
53. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas
54. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: Studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers
55. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma
56. Diet, acetylator phenotype, and risk of colorectal neoplasia
57. Variants at the secretory phospholipase A2 (PLA2G2A) locus: Analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours
58. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer
59. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype?
60. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer
61. N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions
62. Relationship between acetylator status, smoking, diet and colorectal cancer risk in the north-east of England
63. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: A prospective study
64. N-acetyl transferase 1: Two polymorphisms in coding sequence identified in colorectal cancer patients
65. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma
66. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer
67. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients
68. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history
69. Association between H-ras mini-satellite and colorectal cancer risk
70. NAT2, GSTM1, cigarette smoking and risk of colon cancer
71. Relationship between polymorphism of n-acetyltransferase gene and susceptibility to colorectal carcinoma in a chinese population
72. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2
73. Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portugese patients with colorectal cancer
74. Analysis of TNFB and TNFA Ncol RFLP in colorectal cancer
75. Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas
76. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews
77. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma
78. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer
79. Polymorphism of glutathione S-transferase loci GSTM1 and GSTT1 and susceptibility to colorectal cancer in Egypt
80. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer
81. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism
82. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer
83. A polymorphism of the methionine synthase gene: Association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk
84. The 677C > T mutation in 5, 10-methylenetetrahydrofolate reductase and colorectal cancer risk
85. Glutathione S-transferase (GST) M1, T1, P1, N-acetyltransferase (NAT) I and 2 genetic polymorphisms and susceptibility to colorectal cancer
86. Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps
87. Folate intake and carcinogenesis of the colon and rectum
88. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men
89. High-meat diets and cancer risk
90. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer
91. Cigarette smoking in relation to risk of large bowel cancer in women
92. Lifetime cigarette smoking and colorectal cancer incidence in the Physicians’ Health Study I
93. Cigarette smoking and risk of cancers of the colon and rectum: A case-control study from Italy
94. Genetic association studies of bronchial asthma - A need for Bonferroni correction?
95. HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years
96. Meta-analyses of randomized controlled trials
97. Meta-analysis: State-of-science
98. CYP2D6 genotyping and the association with lung cancer susceptibility
99. Apolipoprotein E polymorphism and atherosclerosis
100. Use of unlinked genetic markers to detect population stratification in association studies
101. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
102. A discordant-sibship test for disequilibrium and linkage: No need for parental data
103. The transmission/disequilibrium test and parentalgenotype reconstruction: The reconstruction-combined transmission/disequilibrium test